Copyright Reports & Markets. All rights reserved.

Global Hepatocyte Growth Factor Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Hepatocyte Growth Factor

      • 1.1 Definition of Hepatocyte Growth Factor
      • 1.2 Hepatocyte Growth Factor Segment by Type
        • 1.2.1 Global Hepatocyte Growth Factor Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Beperminogene Perplasmid
        • 1.2.3 FS-101
        • 1.2.4 MP-0250
        • 1.2.5 NDX-1017
        • 1.2.6 NK-4
        • 1.2.7 Others
      • 1.3 Hepatocyte Growth Factor Segment by Applications
        • 1.3.1 Global Hepatocyte Growth Factor Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Coronary Arterial Disease
        • 1.3.3 Arteriosclerosis
        • 1.3.4 Colorectal Cancer
        • 1.3.5 Dementia
        • 1.3.6 Others
      • 1.4 Global Hepatocyte Growth Factor Overall Market
        • 1.4.1 Global Hepatocyte Growth Factor Revenue (2014-2025)
        • 1.4.2 Global Hepatocyte Growth Factor Production (2014-2025)
        • 1.4.3 North America Hepatocyte Growth Factor Status and Prospect (2014-2025)
        • 1.4.4 Europe Hepatocyte Growth Factor Status and Prospect (2014-2025)
        • 1.4.5 China Hepatocyte Growth Factor Status and Prospect (2014-2025)
        • 1.4.6 Japan Hepatocyte Growth Factor Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Hepatocyte Growth Factor Status and Prospect (2014-2025)
        • 1.4.8 India Hepatocyte Growth Factor Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Hepatocyte Growth Factor
      • 2.3 Manufacturing Process Analysis of Hepatocyte Growth Factor
      • 2.4 Industry Chain Structure of Hepatocyte Growth Factor

      3 Development and Manufacturing Plants Analysis of Hepatocyte Growth Factor

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Hepatocyte Growth Factor Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Hepatocyte Growth Factor
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Hepatocyte Growth Factor Production and Capacity Analysis
      • 4.2 Hepatocyte Growth Factor Revenue Analysis
      • 4.3 Hepatocyte Growth Factor Price Analysis
      • 4.4 Market Concentration Degree

      5 Hepatocyte Growth Factor Regional Market Analysis

      • 5.1 Hepatocyte Growth Factor Production by Regions
        • 5.1.1 Global Hepatocyte Growth Factor Production by Regions
        • 5.1.2 Global Hepatocyte Growth Factor Revenue by Regions
      • 5.2 Hepatocyte Growth Factor Consumption by Regions
      • 5.3 North America Hepatocyte Growth Factor Market Analysis
        • 5.3.1 North America Hepatocyte Growth Factor Production
        • 5.3.2 North America Hepatocyte Growth Factor Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Hepatocyte Growth Factor Import and Export
      • 5.4 Europe Hepatocyte Growth Factor Market Analysis
        • 5.4.1 Europe Hepatocyte Growth Factor Production
        • 5.4.2 Europe Hepatocyte Growth Factor Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Hepatocyte Growth Factor Import and Export
      • 5.5 China Hepatocyte Growth Factor Market Analysis
        • 5.5.1 China Hepatocyte Growth Factor Production
        • 5.5.2 China Hepatocyte Growth Factor Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Hepatocyte Growth Factor Import and Export
      • 5.6 Japan Hepatocyte Growth Factor Market Analysis
        • 5.6.1 Japan Hepatocyte Growth Factor Production
        • 5.6.2 Japan Hepatocyte Growth Factor Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Hepatocyte Growth Factor Import and Export
      • 5.7 Southeast Asia Hepatocyte Growth Factor Market Analysis
        • 5.7.1 Southeast Asia Hepatocyte Growth Factor Production
        • 5.7.2 Southeast Asia Hepatocyte Growth Factor Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Hepatocyte Growth Factor Import and Export
      • 5.8 India Hepatocyte Growth Factor Market Analysis
        • 5.8.1 India Hepatocyte Growth Factor Production
        • 5.8.2 India Hepatocyte Growth Factor Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Hepatocyte Growth Factor Import and Export

      6 Hepatocyte Growth Factor Segment Market Analysis (by Type)

      • 6.1 Global Hepatocyte Growth Factor Production by Type
      • 6.2 Global Hepatocyte Growth Factor Revenue by Type
      • 6.3 Hepatocyte Growth Factor Price by Type

      7 Hepatocyte Growth Factor Segment Market Analysis (by Application)

      • 7.1 Global Hepatocyte Growth Factor Consumption by Application
      • 7.2 Global Hepatocyte Growth Factor Consumption Market Share by Application (2014-2019)

      8 Hepatocyte Growth Factor Major Manufacturers Analysis

      • 8.1 Amgen Inc.
        • 8.1.1 Amgen Inc. Hepatocyte Growth Factor Production Sites and Area Served
        • 8.1.2 Amgen Inc. Product Introduction, Application and Specification
        • 8.1.3 Amgen Inc. Hepatocyte Growth Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 AnGes MG, Inc.
        • 8.2.1 AnGes MG, Inc. Hepatocyte Growth Factor Production Sites and Area Served
        • 8.2.2 AnGes MG, Inc. Product Introduction, Application and Specification
        • 8.2.3 AnGes MG, Inc. Hepatocyte Growth Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Kringle Pharma, Inc.
        • 8.3.1 Kringle Pharma, Inc. Hepatocyte Growth Factor Production Sites and Area Served
        • 8.3.2 Kringle Pharma, Inc. Product Introduction, Application and Specification
        • 8.3.3 Kringle Pharma, Inc. Hepatocyte Growth Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 M3 Biotechnology, Inc.
        • 8.4.1 M3 Biotechnology, Inc. Hepatocyte Growth Factor Production Sites and Area Served
        • 8.4.2 M3 Biotechnology, Inc. Product Introduction, Application and Specification
        • 8.4.3 M3 Biotechnology, Inc. Hepatocyte Growth Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Minerva Biotechnologies Corporation
        • 8.5.1 Minerva Biotechnologies Corporation Hepatocyte Growth Factor Production Sites and Area Served
        • 8.5.2 Minerva Biotechnologies Corporation Product Introduction, Application and Specification
        • 8.5.3 Minerva Biotechnologies Corporation Hepatocyte Growth Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Molecular Partners AG
        • 8.6.1 Molecular Partners AG Hepatocyte Growth Factor Production Sites and Area Served
        • 8.6.2 Molecular Partners AG Product Introduction, Application and Specification
        • 8.6.3 Molecular Partners AG Hepatocyte Growth Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 ViroMed Co., Ltd.
        • 8.7.1 ViroMed Co., Ltd. Hepatocyte Growth Factor Production Sites and Area Served
        • 8.7.2 ViroMed Co., Ltd. Product Introduction, Application and Specification
        • 8.7.3 ViroMed Co., Ltd. Hepatocyte Growth Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Yooyoung Pharmaceutical Co., Ltd.
        • 8.8.1 Yooyoung Pharmaceutical Co., Ltd. Hepatocyte Growth Factor Production Sites and Area Served
        • 8.8.2 Yooyoung Pharmaceutical Co., Ltd. Product Introduction, Application and Specification
        • 8.8.3 Yooyoung Pharmaceutical Co., Ltd. Hepatocyte Growth Factor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served

      9 Development Trend of Analysis of Hepatocyte Growth Factor Market

      • 9.1 Global Hepatocyte Growth Factor Market Trend Analysis
        • 9.1.1 Global Hepatocyte Growth Factor Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Hepatocyte Growth Factor Regional Market Trend
        • 9.2.1 North America Hepatocyte Growth Factor Forecast 2019-2025
        • 9.2.2 Europe Hepatocyte Growth Factor Forecast 2019-2025
        • 9.2.3 China Hepatocyte Growth Factor Forecast 2019-2025
        • 9.2.4 Japan Hepatocyte Growth Factor Forecast 2019-2025
        • 9.2.5 Southeast Asia Hepatocyte Growth Factor Forecast 2019-2025
        • 9.2.6 India Hepatocyte Growth Factor Forecast 2019-2025
      • 9.3 Hepatocyte Growth Factor Market Trend (Product Type)
      • 9.4 Hepatocyte Growth Factor Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Hepatocyte Growth Factor Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Hepatocyte Growth Factor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Hepatocyte Growth Factor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hepatocyte Growth Factor market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Hepatocyte Growth Factor in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Hepatocyte Growth Factor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Amgen Inc.
        AnGes MG, Inc.
        Kringle Pharma, Inc.
        M3 Biotechnology, Inc.
        Minerva Biotechnologies Corporation
        Molecular Partners AG
        ViroMed Co., Ltd.
        Yooyoung Pharmaceutical Co., Ltd.

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Beperminogene Perplasmid
        FS-101
        MP-0250
        NDX-1017
        NK-4
        Others

        Segment by Application
        Coronary Arterial Disease
        Arteriosclerosis
        Colorectal Cancer
        Dementia
        Others

        Buy now